Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure (polypharmacy phenogroups and heart failure subgroups outcomes)

Back

ESC2025 Premium Access

Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure (polypharmacy phenogroups and heart failure subgroups outcomes)

Session: Left ventricular outflow tract obstruction

Topic: Pharmacotherapy

Speaker: Doctor A. Aboughalia (Doha, QA)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Ahmad Aboughalia

Hamad General Hospital, Doha (Qatar)

1 follower

6 more presentations in this session

Multicenter study on the effect of Mavacamten on pulmonary artery systolic pressure derived from echo-doppler in obstructive hypertrophic cardiomyopathy

Speaker: Doctor M. Gegenava (Tbilisi, GE)

Comparison of characteristics and outcomes of patients with obstructive vs. non-obstructive hypertrophic cardiomyopathy in a cohort from a referral center in colombia

Speaker: Doctor J. Orozco Burbano (Medellin, CO)

Outcomes of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in Japan

Speaker: Doctor T. Yamaguchi (Tokyo, JP)

Genetic, echocardiographic and clinical determinants of mitral valve abnormalities in hypertrophic cardiomyopathy

Speaker: Miss H. Panholzer (Graz, AT)

Common pathophysiological mechanism of SAM and mitral regurgitation in HOCM

Speaker: Associate Professor Z. Wang (Hangzhou, CN)

Access the full session

Left ventricular outflow tract obstruction

Speakers: Doctor A. Aboughalia, Doctor M. Gegenava, Doctor J. Orozco Burbano, Doctor T. Yamaguchi, Miss H. Panholzer...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources